For laboratory research use only. Not for human consumption.

Research Library

Research Timelines

Chronological overviews of published research for key peptide compounds. Each timeline traces the major discoveries, landmark studies, and evolving scientific understanding that shaped a compound's research trajectory.

Timeline8 milestones

BPC-157 Research Timeline

A chronological overview of published research on Body Protection Compound-157, from its discovery in human gastric juice to modern preclinical studies on tissue repair pathways.

View Timeline →
Timeline8 milestones

GHK-Cu Research Timeline

Tracing the research history of GHK-Cu from its isolation in human plasma in 1973 through gene expression profiling and wound healing studies.

View Timeline →
Timeline8 milestones

Semax Research Timeline

The research history of Semax, from its development as an ACTH 4-10 analog in Russia to modern neurotrophic factor studies and cognitive research.

View Timeline →
Timeline8 milestones

Selank Research Timeline

Tracing the research history of Selank from its design as a tuftsin analog to studies on GABAergic modulation and immunoregulatory mechanisms.

View Timeline →
Timeline8 milestones

MOTS-c Research Timeline

The research history of MOTS-c, from its discovery as the first mitochondrial-derived peptide with metabolic signaling properties to exercise and aging research.

View Timeline →
Timeline8 milestones

PT-141 Research Timeline

The research history of PT-141 (Bremelanotide), from its accidental discovery during tanning peptide research to Phase 3 clinical trials and FDA review.

View Timeline →
Timeline8 milestones

Melanotan II Research Timeline

The research history of Melanotan II, from its synthesis at the University of Arizona as an alpha-MSH analog to melanocortin receptor characterization research.

View Timeline →
Timeline8 milestones

Triple-Receptor Metabolic Signaling Research Timeline

The research history of triple hormone receptor agonism, from single-receptor GLP-1 research through dual agonists to the development of retatrutide as a GIP/GLP-1/glucagon receptor agonist.

View Timeline →
Research Use Compliance

All information presented in this article references published research literature and is intended for educational purposes only. Research peptides are sold strictly for laboratory research use and are not approved for human consumption or medical treatment.